{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:28:00Z","timestamp":1794302880668,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.07.041","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:32:01Z","timestamp":1784853121000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of Retinal Nonperfusion in Diabetic Macular Edema Treated With Brolucizumab Versus Aflibercept: A KINGFISHER Trial Analysis"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0574-1660","authenticated-orcid":false,"given":"MAI","family":"ALHELALY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROUZBEH","family":"ABBASGHOLIZADEH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-8601","authenticated-orcid":false,"given":"YU-CHIEN","family":"CHUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9557-5557","authenticated-orcid":false,"given":"ABBAS","family":"HABIBI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-6124","authenticated-orcid":false,"given":"ALBERTO","family":"QUARTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CEREN","family":"SOYLU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHINICHIRO","family":"CHUJO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YEN-CHUN","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-7910","authenticated-orcid":false,"given":"YE","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-6594","authenticated-orcid":false,"given":"MUNEESWAR G.","family":"NITTALA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-3306","authenticated-orcid":false,"given":"SRINIVAS R.","family":"SADDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL S.","family":"IP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2026.07.041_bib0001","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc22-2503","article-title":"Prevalence, progression, and modifiable risk factors for diabetic retinopathy in youth and young adults with YouthOnset type 1 and type 2 diabetes: the SEARCH for diabetes in youth study","volume":"46","author":"Jensen","year":"2023","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ajo.2026.07.041_bib0002","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.041_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15585\/mmwr.mm7302a5","article-title":"Percentage of adults aged \u226518 years with diagnosed diabetes, by urbanization level and age group \u2014 National Health Interview Survey, United States, 2022","volume":"73","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajo.2026.07.041_bib0004","article-title":"Addressing retinal hypoxia: pathophysiology, therapeutic innovations, and future prospects","volume":"16","author":"Gnanasambandam","year":"2024","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.07.041_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/diab.12.4.293","article-title":"Capillary shunts in the pathogenesis of diabetic retinopathy","volume":"12","author":"Cogan","year":"1963","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.041_bib0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41433-021-01649-0","article-title":"Retinal non-perfusion in diabetic retinopathy","volume":"36","author":"Wykoff","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2026.07.041_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2156273","article-title":"Diabetic macular edema pathophysiology: vasogenic versus inflammatory","volume":"2016","author":"Romero-Aroca","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajo.2026.07.041_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.963615","article-title":"The pathophysiological mechanisms underlying diabetic retinopathy","volume":"10","author":"Wei","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.041_bib0009","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41420-023-01717-2","article-title":"Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.041_bib0010","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bjophthalmol-2020-318726","article-title":"Exploring the angiographic-biologic phenotype in the IMAGINE study: quantitative UWFA and cytokine expression","volume":"106","author":"Abraham","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.07.041_bib0011","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/jcm9051462","article-title":"Relationships among retinal nonperfusion, neovascularization, and vascular endothelial growth factor levels in quiescent proliferative diabetic retinopathy","volume":"9","author":"Ra","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajo.2026.07.041_bib0012","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ophtha.2012.09.032","article-title":"Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"issue":"18","key":"10.1016\/j.ajo.2026.07.041_bib0013","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95530","article-title":"Reversible retinal vessel closure from VEGF-induced leukocyte plugging","volume":"2","author":"Liu","year":"2017","journal-title":"JCI Insight"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2026.07.041_bib0014","first-page":"807","article-title":"Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report Number 11","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2026.07.041_bib0015","first-page":"834","article-title":"Fluorescein angiographic risk factors for progression of diabetic retinopathy: ETDRS report number 13","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.041_bib0016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.oret.2019.05.007","article-title":"Classification and guidelines for widefield imaging: recommendations from the International Widefield Imaging Study Group","volume":"3","author":"Choudhry","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"15","key":"10.1016\/j.ajo.2026.07.041_bib0017","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3390\/jcm10153300","article-title":"Ultrawide field imaging in diabetic retinopathy: exploring the role of quantitative metrics","volume":"10","author":"Ashraf","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajo.2026.07.041_bib0018","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2017.05.024","article-title":"Distribution of nonperfusion area on ultra-widefield fluorescein angiography in eyes with diabetic macular edema: DAVE study","volume":"180","author":"Fan","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.07.041_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2019.04.023","article-title":"Distribution of nonperfusion and neovascularization on ultrawide-field fluorescein angiography in proliferative diabetic retinopathy (RECOVERY study): report 1","volume":"206","author":"Fan","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.07.041_bib0020","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/IAE.0000000000003479","article-title":"Assessment of fluorescein angiography nonperfusion in eyes with diabetic retinopathy using ultrawide field retinal imaging","volume":"42","author":"Silva","year":"2022","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.041_bib0021","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.ophtha.2015.07.034","article-title":"Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.07.041_bib0022","doi-asserted-by":"crossref","unstructured":"Ehlers JP, Jiang AC, Boss JD, et al. Quantitative ultra-widefield angiography and diabetic retinopathy severity: an assessment of panretinal leakage index, ischemic index and microaneurysm count. 2019;126(11):1527-1532. doi:10.1016\/j.ophtha.2019.05.034.","DOI":"10.1016\/j.ophtha.2019.05.034"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.041_bib0023","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2022.3130","article-title":"Association of ultra-widefield fluorescein angiography-identified retinal nonperfusion and the risk of diabetic retinopathy worsening over time","volume":"140","author":"Silva","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.041_bib0024","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/jcm12062406","article-title":"Retinal ischaemia in diabetic retinopathy: understanding and overcoming a therapeutic challenge","volume":"12","author":"Mohite","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajo.2026.07.041_bib0025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41433-021-01750-4","article-title":"Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy","volume":"36","author":"Chatziralli","year":"2022","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.041_bib0026","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1159\/000527378","article-title":"Spontaneous retinal reperfusion of capillary nonperfusion areas in diabetic retinopathy: a comparative angiographic illustration by fluorescence fundus angiography and optic coherence tomography angiography","volume":"13","author":"Hou","year":"2022","journal-title":"Case Rep Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.041_bib0027","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(98)00242-6","article-title":"Reperfusion of occluded capillary beds in diabetic retinopathy","volume":"126","author":"Takahashi","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"10.1016\/j.ajo.2026.07.041_bib0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1167\/iovs.65.13.46","article-title":"Diabetes renders photoreceptors susceptible to retinal ischemia-reperfusion injury","volume":"65","author":"Antonetti","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.041_bib0029","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/aos.15673","article-title":"Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: a meta-analysis of randomised trials","volume":"102","author":"Nanji","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2026.07.041_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/OPTH.S118807","article-title":"Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections","volume":"11","author":"Levin","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.041_bib0031","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ophtha.2019.06.022","article-title":"Widefield OCT-angiography and fluorescein angiography assessments of nonperfusion in diabetic retinopathy and edema treated with anti\u2013vascular endothelial growth factor","volume":"126","author":"Couturier","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2026.07.041_bib0032","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ophtha.2014.03.021","article-title":"Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.041_bib0033","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.oret.2019.09.001","article-title":"Longitudinal panretinal leakage and ischemic indices in retinal vascular disease after aflibercept therapy: the PERMEATE study","volume":"4","author":"Figueiredo","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.041_bib0034","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamaophthalmol.2023.5248","article-title":"Efficacy and safety of brolucizumab for diabetic macular edema: the KINGFISHER randomized clinical trial","volume":"141","author":"Singh","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2026.07.041_bib0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajo.2019.03.030","article-title":"Classification of regions of nonperfusion on ultra-widefield fluorescein angiography in patients with diabetic macular edema","volume":"206","author":"Fang","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.041_bib0036","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.oret.2019.08.008","article-title":"Quantitative ultra-widefield angiographic features and associations with diabetic macular edema","volume":"4","author":"Jiang","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"10.1016\/j.ajo.2026.07.041_bib0037","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1111\/aos.16699","article-title":"Long-term efficacy and safety of brolucizumab in neovascular age-related macular degeneration: a multicentre retrospective real-world study","volume":"102","author":"Kim","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.07.041_bib0038","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41433-020-01309-9","article-title":"Longer-acting treatments for neovascular age-related macular degeneration\u2014present and future","volume":"35","author":"Iglicki","year":"2021","journal-title":"Eye (Lond)"},{"issue":"5706","key":"10.1016\/j.ajo.2026.07.041_bib0039","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.ajo.2026.07.041_bib0040","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1158\/1078-0432.CCR-07-0278","article-title":"Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy","volume":"13","author":"Dickson","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.041_bib0041","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bjo.70.2.114","article-title":"Retinal revascularisation in diabetic retinopathy","volume":"70","author":"Mohan","year":"1986","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.07.041_bib0042","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.18240\/ijo.2021.11.01","article-title":"Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy","volume":"14","author":"Zhu","year":"2021","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.07.041_bib0043","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ophtha.2019.03.040","article-title":"Longitudinal retinal perfusion status in eyes with diabetic macular edema receiving intravitreal aflibercept or laser in VISTA study","volume":"126","author":"Wykoff","year":"2019","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.041_bib0044","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.oret.2019.07.011","article-title":"Intravitreal Aflibercept for Retinal nonperfusion in proliferative diabetic retinopathy: outcomes from the randomized RECOVERY trial","volume":"3","author":"Wykoff","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.041_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.13.12.37","article-title":"The effects of anti-vascular endothelial growth factor loading injections on retinal microvasculature in diabetic macular edema","volume":"13","author":"Kim","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.041_bib0046","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1167\/iovs.17-23509","article-title":"Mechanistic evaluation of panretinal photocoagulation versus aflibercept in proliferative diabetic retinopathy: CLARITY substudy","volume":"59","author":"Nicholson","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:07:57Z","timestamp":1794301677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426004198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S0002939426004198"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.07.041","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Retinal Nonperfusion in Diabetic Macular Edema Treated With Brolucizumab Versus Aflibercept: A KINGFISHER Trial Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}